News

Fastenal's Q3 Performance: Key Metrics Insights and Comparisons

Fastenal's Q3 Performance: Key Metrics Insights and Comparisons

Fastenal's Q3 Earnings Overview

Fastenal (NASDAQ: FAST) has released its financial results for the quarter ending September 2024, revealing a revenue of $1.91 billion. This figure marks a 3.5% increase compared to the same quarter last year. The company's earnings per share (EPS) stood at $0.52, aligning with the previous year's EPS.

Analyzing Revenue Performance

The reported revenue fell short of the consensus estimate provided by analysts, which predicted earnings of approximately $1.92 billion. Despite this minor revenue miss, the EPS matched expectations, indicating consistency in earnings performance.

Understanding the Market Reaction

Investors often scrutinize both year-over-year changes in primary financial metrics—such as revenue and EPS—and their comparison to market expectations to guide their investment decisions. While these headline numbers are pivotal, deeper key metrics offer valuable insights into the company's operational performance.

Key Operational Metrics

Fastenal's performance metrics for the quarter provide additional clarity on its operational effectiveness. Here are the crucial metrics that analysts closely monitored:

  • Business days: 64 Days, matching the average estimate of six analysts.
  • Daily sales: $29.80, slightly below the four-analyst average estimate of $29.92.
  • In-market locations: 3,583, surpassing the estimate of 3,567 by three analysts.
  • FASTBin/FASTVend installations: 123,193, exceeding the average estimate of 122,318.
  • Active Onsite locations: 1,986, edging past the estimate of 1,979.
  • Branch locations: 1,597, slightly ahead of the two-analyst estimate of 1,591.
  • FASTBin/FASTVend signings: 7,281, significantly outperforming the average estimate of 6,570.

Market Position and Future Outlook

In terms of market dynamics, Fastenal's shares have recorded a modest gain of 0.2% during the past month, considerably lower than the S&P 500 composite's increase of 5.4%. Currently, Fastenal holds a Zacks Rank #4, suggesting potential underperformance compared to the broader market in the near future.

Concluding Thoughts

Fastenal's latest earnings report emphasizes its steady operational performance, despite minor misses in revenue expectations. The company's ability to exceed several key operational metrics illustrates its robust business model and ongoing growth initiatives. Investors keen on Fastenal's prospects should continue monitoring these key figures and overall market trends for better insights.

Frequently Asked Questions

What was Fastenal's revenue for Q3?

Fastenal reported a revenue of $1.91 billion for the quarter ended September 2024.

How did Fastenal's EPS perform compared to last year?

The EPS for Fastenal remained consistent at $0.52, the same as the previous year.

What were some key operational metrics for Fastenal?

Key operational metrics include 3,583 in-market locations and 123,193 FASTBin/FASTVend installations.

What is Fastenal's current Zacks Rank?

Fastenal currently has a Zacks Rank #4, indicating a potential underperformance trend.

How did Fastenal's stock perform relative to the S&P 500?

Fastenal's shares increased by 0.2% over the past month, while the S&P 500 composite grew by 5.4%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hidden Assets Guide: Essential Tool for Attorneys

Updated Category News Views 3

Asset Searches: Why They Matter to Lawyers Some days you just have to get into the nitty-gritty of legal legwork, and today feels like one of those days. Asset Search USA has come out swinging with a practical guide that no attorney should ignore, especially if they're dealing with the shadowy world of hidden assets. What are we talking about here? We're talking about...

Continue Reading
State Business Formation Trends: Key Insights for Investors

Updated Category News Views 4

Grasping New Business Formation Shifts The fresh ink isn't dry yet on the latest figures from Registered Agents Inc, revealing a surge in entrepreneurial spark throughout the U.S. September 2026 smashed records with over 562,579 new business registrations—the first time this month crossed the half-million threshold. Quite the feat, really, showcasing a 14% uptick from...

Continue Reading
Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 2

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 4

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 6

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 6

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Ziihera Extends Survival in Advanced GEA: Big Gains Ahead?

Updated Category News Views 5

A Hard Look at Ziihera's Three-Year Survival Story You know the drill—anytime a new drug pulls weight in the cancer arena, ears perk up. Jazz Pharmaceuticals' recent unveil at the 2026 ESMO Congress caught my attention like a solid run on the NASDAQ. We're looking at Ziihera, tangoing with tislelizumab and chemotherapy, hauling serious results against the nasty fight of...

Continue Reading
Ping An Good Doctor Grows 35%: AI's Expanding Role

Updated Category News Views 5

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 1

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 1

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading

Top 5 Most Recently Viewed Articles

Essential Tips for Early Black Friday Cybersecurity Deals

Updated Category News Views 122

Cyber Advice Highlights Early Black Friday Savings in Cybersecurity As the holiday season approaches, many consumers are getting ready for the chaos that Black Friday brings. However, this year, the excitement kicks off earlier than ever, with enticing cybersecurity deals launched by Cyber Advice to meet the growing demand for online safety. With the rise of digital...

Continue Reading
Nayya Receives Investment from Workday Ventures for Growth

Updated Category News Views 95

Nayya's Strategic Investment Journey Nayya, a leading benefits experience platform, is thrilled to announce a new strategic investment from Workday Ventures. This development marks a crucial step in improving how employees select and engage with their benefits. The platform empowers users to make informed choices, ensuring they fully utilize their available options....

Continue Reading
Leadership Changes at Huize Holding Limited: A New Direction

Updated Category News Views 147

Resignation of an Independent Director at Huize Holding Limited In a recent announcement, Huize Holding Limited (NASDAQ: HUIZ), a prominent insurance technology platform in Asia, revealed the resignation of Mr. Aaron Xiaolei Hou from his role as an independent director of the company. Effective September 30, 2025, Mr. Hou's decision to step down is attributed to personal...

Continue Reading
Discover the Charm of Hubei Village in China

Updated Category News Views 129

Exploring the Heart of Hubei Village Imagine a journey through the serene rural landscapes of China, a picturesque escape that offers a glimpse into the everyday lives of its residents. Hubei Village, often referred to as the "Altay of Jiangxi," is an ideal destination for those seeking to experience the beauty of Chinese village life. This captivating village, nestled...

Continue Reading
Understanding Kohl's (KSS) Options Activity: A Deep Dive

Updated Category News Views 141

Unveiling the Intriguing Options Activity Surrounding Kohl's Recently, significant investments have emerged concerning Kohl's (KSS). High-stakes investors appear to be adopting a bullish outlook on the retail giant. This trend should certainly pique the interest of retail traders. Our analysis today reveals critical information drawn from publicly available options...

Continue Reading